Events, Illness, Manufacturing and Vaccination

Commissioner Makary Charts a New Course for FDA at FDLI Annual Conference

FDA Law

MAY 15, 2025

Livornese Dr. Marty Makary took the stage on Thursday at the Food and Drug Law Institutes Annual Conference , continuing the tradition of Commissioners speaking at this event, but with a tone and tempo distinctly his own. He also specifically mentioned rare diseases here , in addition to his example of late-stage illnesses.

Manufacturing

Manufacturing Vaccination Illness IT

The MAHA Assessment’s Implications: Drugs (Part One)

FDA Law

JUNE 4, 2025

There are also drugs the Assessment identifies as being used off-label without high-quality evidence or for uses that are approved but without rigorous true placebo-controlled trials (namely vaccines) and/or with known safety concerns. That leaves us to speculate what the implications of this Assessment will be.

Chronic Disease

Chronic Disease Government Chronic Condition Vaccination

Primary Care Digest

Commissioner Makary Charts a New Course for FDA at FDLI Annual Conference

The MAHA Assessment’s Implications: Drugs (Part One)

Webinars

Stay Connected